Searchable abstracts of presentations at key conferences in endocrinology

ea0019p270 | Pituitary | SFEBES2009

Factors determining the remission of microprolactinomas after dopamine agonist withdrawal

Huda M , Athauda N , Teh M , Carroll P , Powrie J

Background: Withdrawal of dopamine agonist (DA) therapy in the management of microprolactinoma is common practice. It is unclear however which patients are likely to attain long term remission.Aims: The aim of this prospective study was to identify clinical factors that might predict long term remission.Subjects: Fourty subjects (39 female, aged 24–60 years) with microprolactinoma; all had been normoprolactinaemic on DA therap...

ea0019p269 | Pituitary | SFEBES2009

The management of microprolactinoma: are we following the guidelines for dopamine agonist withdrawal?

Huda M , Wee J , Kwok H , Lawrence U , Moore R , Scally L , Gibbs C , Tremble J

Background: Dopamine agonist (DA) withdrawal is common in the management of microprolactinoma. Guidelines in 19971 and 20062 suggest that DA should be withdrawn after normoprolactinaemia for 3 years.Aims: To assess DA withdrawal and adherence to guidelines.Methods: We retrospectively examined casenotes from 1997 to 2008. Patients were included with clinical and biochemical evidence of hyperprolactinaemia, and ...

ea0007p24 | Cytokines and growth factors | BES2004

Excessive daytime sleepiness associated with hypercytokinaemia in POEMS

Wong S , Cresswell P , English P , Wilding J , Huda M , Pazmany L , Pinkney J , Hart I

The multisystem disorder POEMS (polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes) is a rare plasma cell dyscrasia. Elevated cytokines may contribute to its pathogenesis. We describe a POEMS patient with elevated plasma cytokines and excessive daytime sleepiness (EDS).A 39-year-old white woman with IgA lambda and IgG kappa paraproteinaemia, peripheral axonal sensorimotor neuropathy, moderate anascara, skin thickening a...

ea0007p53 | Diabetes, metabolism and cardiovascular | BES2004

Investigation and management of severe hyponatraemia - cause for concern?

Huda M , Gill G , Wile D , Skagen K , Boyd A , Watson I , van Heynigen C

Hyponatraemia is a common biochemical abnormality associated with significant mortality. However, adequate investigation and accurate diagnosis are frequently lacking. We have evaluated the assessment and management of severe hyponatraemia in a large teaching hospital. Inpatients with a plasma sodium (pNa) <125mmol/L were identified prospectively by laboratory database, over a 6 month period. Notes were examined and data extracted. Data was also retrospectively reviewed by ...

ea0007p75 | Diabetes, metabolism and cardiovascular | BES2004

Characteristics and outcome of severe hyponatraemia - a case control study

Gill G , Huda M , Wile D , Boyd A , Skagen K , Watson I , van Heynigen C

Hyponatraemia is one of the commonest biochemical abnormalities in hospitalised patients, and is generally associated with a poor outcome. Large controlled studies of severely hyponatraemic patients are however unusual. From our biochemistry laboratory database we prospectively collected all patients with a sodium (Na) <125 mmol/L over a 6 month period (n=104).For each hyponatraemic case, a normotraemic control was chosen as the next sequential patient in time on the labora...